Short bowel syndrome
CL Donohoe, JV Reynolds - The surgeon, 2010 - Elsevier
The short bowel syndrome (SBS) is a state of malabsorption following intestinal resection
where there is less than 200 cm of intestinal length. The management of short bowel …
where there is less than 200 cm of intestinal length. The management of short bowel …
Growth factors: possible roles for clinical management of the short bowel syndrome
ME McMellen, D Wakeman, SW Longshore… - Seminars in pediatric …, 2010 - Elsevier
The structural and functional changes during intestinal adaptation are necessary to
compensate for the sudden loss of digestive and absorptive capacity after massive intestinal …
compensate for the sudden loss of digestive and absorptive capacity after massive intestinal …
Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease
AL Buchman, S Katz, JC Fang… - Inflammatory bowel …, 2010 - academic.oup.com
Background Teduglutide, an analog of glucagon-like peptide-2 (GLP-2), is associated with
trophic effects on gut mucosa. Its role in the treatment of active Crohn's disease (CD) was …
trophic effects on gut mucosa. Its role in the treatment of active Crohn's disease (CD) was …
[HTML][HTML] The effect of glucagon-like peptide 2 injection on performance, small intestinal morphology, and nutrient transporter expression of stressed broiler chickens
XF Hu, YM Guo, BY Huang, S Bun, LB Zhang, JH Li… - Poultry Science, 2010 - Elsevier
An experiment was conducted to determine the effect of injecting glucagon-like peptide 2
(GLP-2) on the small intestinal weight, morphology, and nutrient transporter expression in …
(GLP-2) on the small intestinal weight, morphology, and nutrient transporter expression in …
The assessment, and glucagon-like peptide-2 modulation, of intestinal absorption and function
DL Sigalet, V Lam, D Boctor - Seminars in pediatric surgery, 2010 - Elsevier
The treatment of patients with short bowel syndrome is hampered by a lack of treatment and
measurement methods. This article reviews our evolving understanding of the role of …
measurement methods. This article reviews our evolving understanding of the role of …
The effect of glucagon‐like peptide‐2 receptor agonists on colonic anastomotic wound healing
HA Redstone, WD Buie, DA Hart… - Gastroenterology …, 2010 - Wiley Online Library
Background. Glucagon‐like peptide 2 (GLP‐2) is an intestinal specific trophic hormone, with
therapeutic potential; the effects on intestinal healing are unknown. We used a rat model of …
therapeutic potential; the effects on intestinal healing are unknown. We used a rat model of …
[图书][B] Nutritional management of digestive disorders
B Banerjee - 2010 - taylorfrancis.com
Thanks to new tools of research and the heightened scientific rigor with which they are
applied, medical science has reached a far more heightened understanding of nutrition's …
applied, medical science has reached a far more heightened understanding of nutrition's …
Butyrate-induced expression of proglucagon: implications for enteroendocrine signaling and intestinal growth
JN Woodard - 2010 - ideals.illinois.edu
While the gastrointestinal tract is primarily recognized for its digestive and absorptive
capacity, it is also the largest endocrine organ in the body. There are a number of different …
capacity, it is also the largest endocrine organ in the body. There are a number of different …